The contribution of staff of Charles River Laboratories Den Bosch B.V. and France Safety Assessment SAS (previously Wil Research Europe in Den Bosch and Lyon) in carrying out the safety pharmacology and 2 week repeated dose toxicity studies is acknowledged as is the Bioreliance Corporation staff for carrying out the Ames test. The authors thank Helena Geys for statistical analysis support in the rat in vivo micronucleus test.